Member Info for ihowells

There’s a strange colour of blue against IQAI today. What’s that all about? :-)

Quiet even…

Qiet on here today especially after the presentation today. What were peoples thoughts?

Proposed uses for the proposed Fundraise
US$M
Capex (1)
$43.0
Additional working capital and other (2)
$19.0
Engineering studies and design for Araguaia line 2
$3.0
Corporate
$5.0
Total uses of funds
$70.0

No doubt the £5m is just in case JM’s office goldfish need more food!

Closed all my spread bet positions I have held for years at 92.67. Will keep my physical position but will not be blinkered going forward. Will trade my positions going forward.

Bet DJ feels as though as he has run over a black cat!

Diluted not by an extra $61m but by $70m. Guess JM and board showing their true wings here!

I guess the interesting thing here are JM’s comments in the past. Looking for non -dilutive finance raises and this is what we get….pigs in a trough!

Well I didn’t see that one coming!

Great post Bojo!

Ah my mistake. Would be great to get feedback from people able to attend. It looks like we will get to the promised land, it’s just a question when.

The AGM is October 28th.

Pharma services business momentum - discussions in progress with more than twenty biopharma companies offering a pipeline of opportunities for new contracts as we move through the end of this year and into 2023. Almost all potential customers are interested in bespoke assay development

· Global sales and distribution network being established with first contracts in negotiation and initial seeding of instruments anticipated

· Accreditation of clinical laboratories in final stages offering ability to offer validated tests for both pharma services and patient management in coming months

· New product roll-out to accelerate with a pipeline of sample-to-answer imaging and molecular solutions being finalised for offer to customers

· Numerous discussions in progress with potential partners including medtech companies, downstream assay providers and clinical laboratories regarding selected Parsortix based assays

I liked this part but also the Ovarian study showing best in class.

Lawrence, get a grip! Richie was merely making the point that many Tory ministers will follow PM’s mantra despite it possibly being ethically wrong. Try reading between the lines a bit.

These are the standouts,

None of the portfolio companies are yet at the traditional point of exit where value can be maximised.

The reduction in assets under management was also a key driver of a reduction in net asset value per share from 9.2p at 31 December 2021 to 8.5p at 30 June 2022.

No mention at all of the US OTC listing either

No wonder the SP was smashed at outset and down 14%. AS really has to go.

Well I guess if people who follow other boards, will realise the buyer of the cluster of £14.91k trades. Hope he makes his money back here of course….

I think the DFS for Vermelho is due to be completed around Q4 2023 when the building of Araguaia, if on timescale, is due to be completed. Of course it would be good to hear news on its progress in the interim also. Especially as JM has stated his belief that there is little chance of us running both mines as a sole company.

I hope Nicole doesn’t mind the quotations included getting her gender wrong. ;-)

Bet that got peoples hearbeats going? Exercise of options, guess they are still confident of a positive outcome but guess more selling into a spike. GLA.

…we have finance….should have proof read.

Frustrating to see us drift under the £1 level or 5p in old money. It is what it is but I am glad you have finance sorted rather than trying to raise in this market environment. Long term hold for me until production but who knows if something surfaces before.